Blockade of t lymphocyte down-regulation associated with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 38/17 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) C07K 14/31 (2006.01) C07K 14/705 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2239448

T cell activation in response to antigen is increased by the administration of binding agents that block CTLA-4 signaling. When CTLA-4 signaling is thus blocked, the T cell response to antigen is released from inhibition. Such an enhanced response is useful for the treatment of tumors, chronic viral infections, and as an adjuvant during immunization.

L'activation de lymphocytes T en réponse à un antigène est accrue par l'administration d'agents de liaison qui bloquent la signalisation par CTLA-4. Lorsque la signalisation par CTLA-4 est ainsi bloquée, la réponse des lymphocytes T à l'antigène est libérée de toute inhibition. Une telle réponse améliorée est utile pour traiter les tumeurs et les infections virales chroniques et comme adjuvant lors d'une immunisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Blockade of t lymphocyte down-regulation associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blockade of t lymphocyte down-regulation associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blockade of t lymphocyte down-regulation associated with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2049602

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.